Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 08-Apr-24 4:11 PM View:  | Prelude Therapeutics Inc (PRLD) | 04-Apr-24 | Payment of Exercise | 3,347 | $4.74 | $15,864.80 | (6%) 54.63K to 51.29K | |
| 08-Apr-24 4:11 PM View: | Prelude Therapeutics Inc (PRLD) | 04-Apr-24 | Option Exercise | 9,375 | -- | -- | 21% 45.26K to 54.63K | |
| 08-Jan-24 5:00 PM View: | Prelude Therapeutics Inc (PRLD) | 04-Jan-24 | Payment of Exercise | 3,844 | $3.77 | $14,491.90 | (8%) 49.1K to 45.26K | |
| 08-Jan-24 5:00 PM View: | Prelude Therapeutics Inc (PRLD) | 04-Jan-24 | Option Exercise | 9,375 | -- | -- | 24% 39.73K to 49.1K | |
| 06-Oct-23 9:07 AM View: | Prelude Therapeutics Inc (PRLD) | 04-Oct-23 | Option Exercise | 9,375 | -- | -- | 31% 30.35K to 39.73K | |
| 06-Jul-23 4:35 PM View: | Prelude Therapeutics Inc (PRLD) | 04-Jul-23 | Payment of Exercise | 3,242 | $4.65 | $15,075.30 | (10%) 33.59K to 30.35K | |
| 06-Jul-23 4:35 PM View: | Prelude Therapeutics Inc (PRLD) | 04-Jul-23 | Option Exercise | 9,375 | -- | -- | 39% 24.22K to 33.59K | |
| 06-Apr-23 6:19 PM View: | Prelude Therapeutics Inc (PRLD) | 06-Apr-23 | Option Sale | 13,280 | $6.12 | $81,273.60 | (35%) 37.5K to 24.22K | |
| 06-Apr-23 6:19 PM View: | Prelude Therapeutics Inc (PRLD) | 04-Apr-23 | Option Exercise | 37,500 | -- | -- | 100% 0 to 37.5K | |
| 16-Dec-21 5:50 PM View: | Beigene, Ltd. (BGNE) | 14-Dec-21 | Option Exercise | 1,500 | $119.96 | $179,940.00 | < 1% 160.06K to 161.56K | |
| 16-Dec-21 5:50 PM View: | Beigene, Ltd. (BGNE) | 14-Dec-21 | Market Option Sale (Planned) | 1,500 | $278.14 | $417,211.00 | (< 1%) 161.56K to 160.06K | |
| 02-Dec-21 6:21 PM View: | Beigene, Ltd. (BGNE) | 01-Dec-21 | Market Sale | 1,049 | $359.86 | $377,493.00 | (< 1%) 161.1K to 160.06K | |
| 02-Dec-21 6:21 PM View: | Beigene, Ltd. (BGNE) | 30-Nov-21 | Grant | 15,869 | -- | -- | 11% 145.24K to 161.1K | |
| 19-Nov-21 6:18 PM View: | Beigene, Ltd. (BGNE) | 17-Nov-21 | Option Exercise | 1,500 | $119.96 | $179,940.00 | 1% 145.24K to 146.74K | |
| 19-Nov-21 6:18 PM View: | Beigene, Ltd. (BGNE) | 17-Nov-21 | Market Option Sale (Planned) | 1,500 | $381.34 | $572,003.00 | (1%) 146.74K to 145.24K | |
| 21-Oct-21 5:37 PM View: | Beigene, Ltd. (BGNE) | 19-Oct-21 | Option Exercise | 1,500 | $119.96 | $179,940.00 | 1% 145.24K to 146.74K | |
| 21-Oct-21 5:37 PM View: | Beigene, Ltd. (BGNE) | 19-Oct-21 | Market Option Sale (Planned) | 1,500 | $372.77 | $559,163.00 | (1%) 146.74K to 145.24K | |
| 22-Sep-21 10:00 PM View: | Beigene, Ltd. (BGNE) | 20-Sep-21 | Option Exercise | 6,000 | $119.96 | $719,760.00 | 4% 145.24K to 151.24K | |
| 22-Sep-21 10:00 PM View: | Beigene, Ltd. (BGNE) | 20-Sep-21 | Market Option Sale (Planned) | 6,000 | $397.96 | $2,387,770.00 | (4%) 151.24K to 145.24K | |
| 15-Sep-21 6:16 PM View: | Beigene, Ltd. (BGNE) | 13-Sep-21 | Market Sale (Planned) | 12,901 | $358.14 | $4,620,390.00 | (8%) 158.14K to 145.24K | (3%) |
| 02-Sep-21 8:39 PM View: | Beigene, Ltd. (BGNE) | 02-Sep-21 | Market Sale | 545 | $327.18 | $178,314.00 | (< 1%) 313.49K to 312.95K | |
| 02-Sep-21 8:39 PM View: | Beigene, Ltd. (BGNE) | 01-Sep-21 | Grant | 7,669 | -- | -- | 3% 306.37K to 314.04K | |
| 02-Sep-21 8:39 PM View: | Beigene, Ltd. (BGNE) | 01-Sep-21 | Market Sale | 542 | $310.53 | $168,307.00 | (< 1%) 314.04K to 313.49K | |
| 02-Sep-21 8:39 PM View: | Beigene, Ltd. (BGNE) | 31-Aug-21 | Grant | 7,705 | -- | -- | 3% 298.66K to 306.37K | |
| 19-Jul-21 4:43 PM View: | Beigene, Ltd. (BGNE) | 15-Jul-21 | Option Exercise | 21,000 | $146.90 | $3,085,000.00 | 7% 298.66K to 319.66K | |
| 19-Jul-21 4:43 PM View: | Beigene, Ltd. (BGNE) | 15-Jul-21 | Market Option Sale (Planned) | 21,000 | $332.42 | $6,980,770.00 | (7%) 319.66K to 298.66K | |
| 30-Jun-21 4:49 PM View: | Beigene, Ltd. (BGNE) | 29-Jun-21 | Option Exercise | 1,500 | $29.49 | $44,235.00 | < 1% 298.66K to 300.16K | |
| 30-Jun-21 4:49 PM View: | Beigene, Ltd. (BGNE) | 29-Jun-21 | Market Option Sale (Planned) | 1,075 | $352.13 | $378,542.00 | (< 1%) 300.16K to 299.09K | |
| 30-Jun-21 4:49 PM View: | Beigene, Ltd. (BGNE) | 29-Jun-21 | Market Sale (Planned) | 425 | $352.13 | $149,656.00 | (< 1%) 299.09K to 298.66K | |
| 30-Jun-21 4:49 PM View: | Beigene, Ltd. (BGNE) | 28-Jun-21 | Market Option Sale | 425 | $365.00 | $155,125.00 | (< 1%) 299.09K to 298.66K | 2% |
| 21-Jun-21 4:45 PM View: | Beigene, Ltd. (BGNE) | 18-Jun-21 | Market Sale | 469 | $325.66 | $152,733.00 | (< 1%) 304.65K to 304.19K | |
| 21-Jun-21 4:45 PM View: | Beigene, Ltd. (BGNE) | 16-Jun-21 | Grant | 25,350 | -- | -- | 9% 279.31K to 304.65K | |
| 09-Jun-21 4:45 PM View: | Beigene, Ltd. (BGNE) | 07-Jun-21 | Market Sale | 603 | $351.55 | $211,986.00 | (< 1%) 285.54K to 284.93K | 1% |
| 02-Jun-21 4:40 PM View: | Beigene, Ltd. (BGNE) | 01-Jun-21 | Market Sale | 540 | $362.64 | $195,828.00 | (< 1%) 293.31K to 292.77K | |
| 02-Jun-21 4:40 PM View: | Beigene, Ltd. (BGNE) | 31-May-21 | Grant | 7,729 | -- | -- | 3% 285.58K to 293.31K | |
| 02-Jun-21 4:40 PM View: | Beigene, Ltd. (BGNE) | 28-May-21 | Option Exercise | 1,500 | $29.49 | $44,235.00 | < 1% 285.58K to 287.08K | |
| 02-Jun-21 4:40 PM View: | Beigene, Ltd. (BGNE) | 28-May-21 | Market Option Sale (Planned) | 1,500 | $356.30 | $534,453.00 | (< 1%) 287.08K to 285.58K | |
| 03-May-21 4:35 PM View: | Beigene, Ltd. (BGNE) | 29-Apr-21 | Option Exercise | 1,500 | $29.49 | $44,235.00 | < 1% 285.58K to 287.08K | |
| 03-May-21 4:35 PM View: | Beigene, Ltd. (BGNE) | 29-Apr-21 | Market Option Sale (Planned) | 1,500 | $354.92 | $532,387.00 | (< 1%) 287.08K to 285.58K | |
| 31-Mar-21 4:46 PM View: | Beigene, Ltd. (BGNE) | 29-Mar-21 | Option Exercise | 1,500 | $29.49 | $44,235.00 | < 1% 285.58K to 287.08K | |
| 31-Mar-21 4:46 PM View: | Beigene, Ltd. (BGNE) | 29-Mar-21 | Market Option Sale (Planned) | 1,500 | $323.99 | $485,993.00 | (< 1%) 287.08K to 285.58K | |
| 02-Mar-21 4:52 PM View: | Beigene, Ltd. (BGNE) | 26-Feb-21 | Option Exercise | 1,500 | $29.49 | $44,235.00 | < 1% 285.58K to 287.08K | |
| 02-Mar-21 4:52 PM View: | Beigene, Ltd. (BGNE) | 26-Feb-21 | Market Option Sale (Planned) | 1,500 | $320.73 | $481,099.00 | (< 1%) 287.08K to 285.58K | |
| 02-Feb-21 4:49 PM View: | Beigene, Ltd. (BGNE) | 29-Jan-21 | Option Exercise | 1,500 | $29.49 | $44,235.00 | < 1% 285.58K to 287.08K | |
| 02-Feb-21 4:49 PM View: | Beigene, Ltd. (BGNE) | 29-Jan-21 | Market Option Sale (Planned) | 1,500 | $322.99 | $484,492.00 | (< 1%) 287.08K to 285.58K | |
| 30-Dec-20 4:34 PM View: | Beigene, Ltd. (BGNE) | 29-Dec-20 | Option Exercise | 1,500 | $29.49 | $44,235.00 | < 1% 285.58K to 287.08K | |
| 30-Dec-20 4:34 PM View: | Beigene, Ltd. (BGNE) | 29-Dec-20 | Market Option Sale (Planned) | 1,500 | $249.13 | $373,690.00 | (< 1%) 287.08K to 285.58K | |
| 02-Dec-20 5:01 PM View: | Beigene, Ltd. (BGNE) | 30-Nov-20 | Option Exercise | 1,500 | $29.49 | $44,235.00 | < 1% 285.58K to 287.08K | |
| 02-Dec-20 5:01 PM View: | Beigene, Ltd. (BGNE) | 30-Nov-20 | Market Option Sale (Planned) | 1,500 | $267.82 | $401,723.00 | (< 1%) 287.08K to 285.58K | 2% |
| 02-Nov-20 4:44 PM View: | Beigene, Ltd. (BGNE) | 29-Oct-20 | Option Exercise | 1,500 | $29.49 | $44,235.00 | < 1% 285.58K to 287.08K |